Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
(56)
•••
unplugged1
X
View Profile
View Bullboard History
Post by
unplugged1
on Feb 02, 2024 9:24am
Retired Police Captain Try's MJ for the First Time
For advanced Parkinson's. https://www.youtube.com/watch?v=zNT8Zo_sfwo
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Feb 02, 2024 9:14am
RE:mdjbrown...re DEA: Imho they are playing the political card
Anne M, head of the DEA....ONLY answers to the President. Don't forget that.
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Feb 02, 2024 9:13am
mdjbrown...re DEA: Imho they are playing the political card
and 'timing' it to give Biden a boost in the polls. The theme? A President that's in touch with the people and understands the medical benefits.
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Feb 02, 2024 9:10am
I think we are in a "quiet period" because no updates
on Anvisa or FDA pharma partner NDA approval. What's the $package$ for us because we're going to make a sht load of money. That is confirmed by my Eternal Companion π, Athea
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Feb 02, 2024 9:00am
LABS and Pfizer: New cancer drugs, W.H.O. 1 in 5
....is it because the Planet π is emitting more neutrinos at an accelerated rate? Neutrino production is sourced from radioactive decay of iron...that's a tremendous amount of heat and
...more
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Post by
mdjbrown
on Feb 01, 2024 11:12pm
Tic Toc goes the clock, DEA
https://www.marijuanamoment.net/senators-tell-dea-to-fully-legalize-marijuana-demanding-answers-on-rescheduling-process/
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Post by
mdjbrown
on Feb 01, 2024 10:47pm
They cant hold this back forever!
https://www.globenewswire.com/news-release/2024/01/29/2818990/0/en/CBD-Ingredient-Market-Exclusive-Report-2024-2031-InsightAce-Analytic.html
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Feb 01, 2024 7:03pm
RE:EBITDA
Avicanna 'expanded manufacturing agreement' and a positve EBITDA for 4qrt.
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Feb 01, 2024 4:13pm
RE:RE:EBITDA
I'm expecting profitability 2024 based conservative trajectory of the previous 4qs of financials, the "additional 3m annually" cost savings commencing q4, and the state of international
...more
(7)
•••
Hunter34
X
View Profile
View Bullboard History
Comment by
Hunter34
on Feb 01, 2024 3:15pm
RE:EBITDA
Hoping against hope as this Industry was targeted for destruction from the outset...
(137)
•••
subaru1
X
View Profile
View Bullboard History
Post by
subaru1
on Feb 01, 2024 2:28pm
EBITDA
How many of you here think that the EBITDA will be positive for the 4qrt, personnaly i would be very surprised, my take is between -500 to a - 1million.
(137)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Feb 01, 2024 11:57am
RE:We are way past due on news regarding FDA, ANVISA,
Based on your last 2 years post we are way past due for sure, may be in a week a month or a year a news will come.
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Feb 01, 2024 11:05am
We are way past due on news regarding FDA, ANVISA,
and their global pharma partner, something big is building up. I'll say at this point in time: Pfizer and new cancer drugs.
(615)
•••
okgonow
X
View Profile
View Bullboard History
Post by
okgonow
on Feb 01, 2024 7:53am
Just a Thought
a little of topic more of a general observation regarding these Boards. it alway amazes me that there are some on these boards that are quite underhanded and post FUD( Fear, uncertainty and
...more
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >